PEDF is also able to increase PC cell sensitivity to chemotherapy by upregulating Il-8/C-X-C motif receptor 1 (CXCR1) signalling and reducing PC cell proliferation, with potential to reduce the occurrence and burden of clinical PC metastases [34]. Here, CXCL8 is linked to pachyonychia congenita.